BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33106839)

  • 1. Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populations.
    Yang W; Devidas M; Liu Y; Smith C; Dai Y; Winick N; Hunger SP; Loh ML; Raetz EA; Larsen EC; Carroll WL; Winter SS; Dunsmore KP; Mattano LA; Relling MV; Karol SE
    Blood; 2021 Mar; 137(11):1550-1552. PubMed ID: 33106839
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic Biomarkers to Identify the Risk of Osteonecrosis in Children with Acute Lymphoblastic Leukemia.
    den Hoed MA; Pluijm SM; Uitterlinden AG; Pieters R; van den Heuvel-Eibrink MM
    Mol Diagn Ther; 2016 Dec; 20(6):519-522. PubMed ID: 27365083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patients.
    Gagné V; Aubry-Morin A; Plesa M; Abaji R; Petrykey K; St-Onge P; Beaulieu P; Laverdière C; Alos N; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
    Pharmacogenomics; 2019 Nov; 20(17):1189-1197. PubMed ID: 31686588
    [No Abstract]   [Full Text] [Related]  

  • 4. Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia.
    Bond J; Adams S; Richards S; Vora A; Mitchell C; Goulden N
    Blood; 2011 Sep; 118(9):2632-3. PubMed ID: 21885611
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia.
    Karol SE; Mattano LA; Yang W; Maloney KW; Smith C; Liu C; Ramsey LB; Fernandez CA; Chang TY; Neale G; Cheng C; Mardis E; Fulton R; Scheet P; San Lucas FA; Larsen EC; Loh ML; Raetz EA; Hunger SP; Devidas M; Relling MV
    Blood; 2016 Feb; 127(5):558-64. PubMed ID: 26590194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.
    Kawedia JD; Kaste SC; Pei D; Panetta JC; Cai X; Cheng C; Neale G; Howard SC; Evans WE; Pui CH; Relling MV
    Blood; 2011 Feb; 117(8):2340-7; quiz 2556. PubMed ID: 21148812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia.
    Karol SE; Yang W; Van Driest SL; Chang TY; Kaste S; Bowton E; Basford M; Bastarache L; Roden DM; Denny JC; Larsen E; Winick N; Carroll WL; Cheng C; Pei D; Fernandez CA; Liu C; Smith C; Loh ML; Raetz EA; Hunger SP; Scheet P; Jeha S; Pui CH; Evans WE; Devidas M; Mattano LA; Relling MV
    Blood; 2015 Oct; 126(15):1770-6. PubMed ID: 26265699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor-1 and osteonecrosis risk in childhood acute lymphoblastic leukemia.
    Sherief LM; Beshir M; Raafat N; Abdelkhalek ER; Mokhtar WA; Elgerby KM; Soliman BK; Salah HE; Mokhtar GA; Kamal NM; ELsayed H; Zakaria M
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1700. PubMed ID: 34042331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeats in the kringle IV encoding domains in the Apo(a) gene and serum lipoprotein(a) level do not contribute to the risk for avascular necrosis of the bone (AVN) in pediatric acute lymphoblastic leukemia.
    van Beek RD; Bezemer DD; Meijerink JP; de Muinck Keizer-Schrama SM; Haas OA; Te Winkel L; Pieters R; van den Heuvel-Eibrink M
    Leukemia; 2006 May; 20(5):879-80. PubMed ID: 16525499
    [No Abstract]   [Full Text] [Related]  

  • 10. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    French D; Hamilton LH; Mattano LA; Sather HN; Devidas M; Nachman JB; Relling MV;
    Blood; 2008 May; 111(9):4496-9. PubMed ID: 18285546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the Relationship Between
    Erdem M; Tüfekçi Ö; Kızıldağ S; Yılmaz Ş; Kızmazoğlu D; Eroğlu Filibeli B; Ören H
    Turk J Haematol; 2019 Feb; 36(1):12-18. PubMed ID: 30251958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of hip and knee osteonecrosis and their associations with bone mineral density in children with acute lymphoblastic leukaemia.
    Inaba H; Cao X; Chang JY; Karol SE; Panetta JC; Ness KK; Cheng C; Pui CH; Relling MV; Kaste SC
    Br J Haematol; 2020 May; 189(4):e177-e181. PubMed ID: 32207157
    [No Abstract]   [Full Text] [Related]  

  • 13. Osteonecrosis in children treated for acute lymphoblastic leukemia: a magnetic resonance imaging study after treatment.
    Düzovali O
    Med Pediatr Oncol; 1999 Feb; 32(2):154-5. PubMed ID: 9950209
    [No Abstract]   [Full Text] [Related]  

  • 14. Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP).
    Parasole R; Valsecchi MG; Silvestri D; Locatelli F; Barisone E; Petruzziello F; Putti MC; Micalizzi C; Colombini A; Mura R; Mina T; Testi AM; Notarangelo LD; Santoro N; Casini T; Consarino C; Nigro LL; Ziino O; Giagnuolo G; Rizzari C; Conter V
    Blood Cancer J; 2018 Nov; 8(12):115. PubMed ID: 30442887
    [No Abstract]   [Full Text] [Related]  

  • 15. A
    Zgheib NK; El-Khoury H; Maamari D; Basbous M; Saab R; Muwakkit SA
    Per Med; 2021 Sep; 18(5):431-439. PubMed ID: 34406079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteonecrosis in children with acute lymphoblastic leukemia: a 10-year study from northern Greece.
    Tragiannidis A; Athanassiadou F; Papageorgiou T; Petsatodis G; Sidi V; Koliouskas D
    Pediatr Blood Cancer; 2007 Oct; 49(5):764. PubMed ID: 17216599
    [No Abstract]   [Full Text] [Related]  

  • 17. Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia.
    Te Winkel ML; Pieters R; Wind EJ; Bessems JH; van den Heuvel-Eibrink MM
    Haematologica; 2014 Mar; 99(3):430-6. PubMed ID: 24598854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALL and osteonecrosis.
    Gaynon PS
    Blood; 2015 Oct; 126(15):1734-5. PubMed ID: 26450951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension is a modifiable risk factor for osteonecrosis in acute lymphoblastic leukemia.
    Janke LJ; Van Driest SL; Portera MV; Atreya RV; Denny JC; Pei D; Cheng C; Kaste SC; Inaba H; Jeha S; Pui CH; Relling MV; Karol SE
    Blood; 2019 Sep; 134(12):983-986. PubMed ID: 31409674
    [No Abstract]   [Full Text] [Related]  

  • 20. Heritable variation at the chromosome 21 gene ERG is associated with acute lymphoblastic leukemia risk in children with and without Down syndrome.
    de Smith AJ; Walsh KM; Morimoto LM; Francis SS; Hansen HM; Jeon S; Gonseth S; Chen M; Sun H; Luna-Fineman S; Antillón F; Girón V; Kang AY; Smirnov I; Shao X; Whitehead TP; Barcellos LF; Jolly KW; Healy J; Laverdière C; Sinnett D; Taub JW; Birch JM; Thompson PD; Pombo-de-Oliveira MS; Spector LG; DeWan AT; Mueller BA; Chiang C; Metayer C; Ma X; Wiemels JL
    Leukemia; 2019 Nov; 33(11):2746-2751. PubMed ID: 31296947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.